Spectrum Pharmaceuticals, Inc.
(NASDAQ : SPPI)

( )
SPPI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.81%175.590.7%$1405.98m
PFEPfizer Inc. -1.83%50.400.9%$1327.23m
ABBVAbbVie, Inc. -1.44%152.551.9%$1169.95m
BMYBristol-Myers Squibb Co. -1.52%77.031.0%$1169.89m
MRKMerck & Co., Inc. -1.02%92.050.7%$1097.17m
LLYEli Lilly & Co. -1.98%295.431.1%$859.74m
AZNAstraZeneca Plc -3.53%63.321.0%$489.96m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.09%141.900.0%$438.60m
VERUVeru, Inc. -3.78%15.010.0%$363.86m
NVSNovartis AG -0.27%87.680.2%$229.58m
GSKGlaxoSmithKline Plc -2.42%43.630.2%$222.90m
HZNPHorizon Therapeutics Plc -4.82%88.425.4%$193.67m
SGENSeagen Inc. -2.42%143.005.7%$174.55m
NVONovo Nordisk A/S -2.61%103.560.1%$171.61m
VTRSViatris, Inc. -1.74%11.270.0%$153.78m

Company Profile

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Henderson, NV.